326
Participants
Start Date
August 31, 2006
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
clofarabine (IV formulation)
clofarabine (IV formulation) infusion 40mg/m\^2 / day up to 3 cycles
placebo
placebo (sodium Chloride) 1-hour IV infusion
cytarabine
cytarabine IV infusion 1g/m\^2/day for up to 3 cycles
Universitatsklinikum Ulm, Ulm
Mayo Clinical Hospital, Scottsdale
Arizona Cancer Center, Tucson
University of Arkansas for Medical Sciences, Arkansas Cancer Research Center, Little Rock
Scripps Cancer Center, La Jolla
UCLA School of Medicine, Los Angeles
University of Southern California, Kenneth Norris Cancer Center, Los Angeles
Stanford Comprehensive Cancer Center, Stanford
University of Colorado Health Science Center, Aurora
Rocky Mountain Cancer Center, Denver
Cancer Center of Central Connecticut, Southington
Northwestern University, Chicago
Rush University Medical Center, Chicago
Evanston Northwestern Healthcare, Evanston
University of Kansas Medical Center, Kansas City
University of Kentucky, Markey Cancer Center, Lexington
Louisiana State University Health Science Center, Shreveport
Harold Alfond Center for Cancer Care, Augusta
Beth Israel Deaconess Medical Center, Boston
Josephine Ford Cancer Center, Detroit
Dartmouth Hitchcock Medical Center, Lebanon
The Cancer Center at Hackensack University Medical Center, Hackensack
Roswell Park Cancer Center, Buffalo
Mt. Sinai School of Medicine, New York
New York Medical Center, Valhalla
Mecklenburg Medical Group, Charlotte
Duke University Medical Center, Durham
Wake Forest University School of Medicine, Winston-Salem
Gabrail Cancer Center, Canton
University of Oklahoma Health Sciences Center, Oklahoma City
Oregon Health Science University, Portland
Medical University of South Carolina, Charleston
University of Tennessee Medical Center, Knoxville
Sarah Cannon Research Institute, Nashville
Vanderbilt University Medical Center, Nashville
UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas
MD Anderson Cancer Center, Houston
Cancer Care Centers of South Texas, San Antonio
University of Texas Health Sciences Center, San Antonio
University of Utah - Huntsman Cancer Institute, Salt Lake City
West Virginia University Hospitals, Mary Babb Randolph Cancer Center, Morgantown
Medical College of Wisconsin, Milwaukee
Saint John Regional Hospital, Saint John
Juravinski Cancer Center, Hamilton
Hopital Maisonneuve-Rosemont, Montreal
Service Maladies du Sang, CHU Angers, Angers
Hopital Claude Huriez CHRU de Lille, Lille
Hopital Edouard Herriot, Lyon
Institut Paoli Calmettes, Marseille
Hopital Hotel Dieu, Nantes
Hopital Purpan, Toulouse
Medizinische Hochschule Hannover, Zentrum fur Innere Medizin, Abt. Haematologie / Onkologie, Hanover
Medizinische Klinik der Technischen, Universität München, Munich
Ospedali Riuniti Bergamo, Bergamo
A.O Ospedale Niguarda Ca'Granda, Milan
N.O. San Gerardo, Monza
"Azienda Ospedaliera Antonio Cardarelli", Napoli
Genzyme, a Sanofi Company
INDUSTRY